Australia markets close in 27 minutes

Cognition Therapeutics, Inc. (CGTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.9200-0.0700 (-3.52%)
At close: 04:00PM EDT
2.0200 +0.10 (+5.21%)
After hours: 04:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 76.88M
Enterprise value 48.19M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.14
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.89

Trading information

Stock price history

Beta (5Y monthly) 1.62
52-week change 322.29%
S&P500 52-week change 325.38%
52-week high 33.4900
52-week low 30.9000
50-day moving average 31.9294
200-day moving average 31.6816

Share statistics

Avg vol (3-month) 3199.75k
Avg vol (10-day) 374.35k
Shares outstanding 540.04M
Implied shares outstanding 640.01M
Float 832.92M
% held by insiders 16.31%
% held by institutions 133.58%
Shares short (15 Apr 2024) 4220.34k
Short ratio (15 Apr 2024) 41.4
Short % of float (15 Apr 2024) 40.79%
Short % of shares outstanding (15 Apr 2024) 40.57%
Shares short (prior month 15 Mar 2024) 4228.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-74.08%
Return on equity (ttm)-79.69%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -50.63M
Net income avi to common (ttm)-25.79M
Diluted EPS (ttm)-0.8600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)29.92M
Total cash per share (mrq)0.77
Total debt (mrq)1.24M
Total debt/equity (mrq)5.06%
Current ratio (mrq)3.37
Book value per share (mrq)0.76

Cash flow statement

Operating cash flow (ttm)-16.02M
Levered free cash flow (ttm)-23.04M